Managed Health Care Connect February 9, 2018
One year ago, the FDA released the health care economic information (HCEI) draft guidance on approved communication between pharmaceutical manufacturers and health care decision-makers, including payers, formulary committees, or similar entities. First Report Managed Care spoke with stakeholders for their insights and experiences on why access to HCEI is critical to better care for patients, how the guidance has impacted payers, why it is important to continue incorporating HCEI into decision making while waiting for FDA to finalize the guidelines, and where industry stands on HCEI a year later.
The Value of Access
HCEI, which is part of the 21st Century Cures Act, is an important consideration during the formulary decision-making process, according to Jay Jackson, PharmD, MPH, senior vice...